← Back to Search

Multicomponent Nutrition Supplement

Nutrition for Brain and Body Health (BB-Health) Feasibility Trial (BB-Health Trial)

N/A
Waitlist Available
Led By Susan B. Roberts, Ph.D.
Research Sponsored by Tufts University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up measure at baseline (pre-randomization), and 3, 6 and 12 months after randomization

Summary

This trial is testing a specific diet to see if it can improve cognition and brain blood flow in older adults at risk for cognitive decline.

Eligible Conditions
  • Obesity
  • Cognition

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~measure at baseline (pre-randomization), and 3, 6 and 12 months after randomization
This trial's timeline: 3 weeks for screening, Varies for treatment, and measure at baseline (pre-randomization), and 3, 6 and 12 months after randomization for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Cognition
Secondary study objectives
Macrovascular cerebral blood flow velocity in fasting state
Macrovascular cerebral blood flow velocity in fed state
Microvascular cerebral blood flow in fasting state
+1 more
Other study objectives
Weight loss

Trial Design

4Treatment groups
Active Control
Placebo Group
Group I: -MCNS-WLActive Control1 Intervention
This group receives the placebo nutrition supplement and is in the control group for the behavioral weight loss intervention (no behavioral intervention during the trial, but participant is wait-listed to receive one after the trial finishes)
Group II: +MCNS+WLActive Control2 Interventions
This group receives the multicomponent nutrition supplement and the behavioral weight loss intervention.
Group III: +MCNS-WLActive Control1 Intervention
This group receives the multicomponent nutrition supplement and is in the control group for the behavioral weight loss intervention (no behavioral intervention during the trial, but participant is wait-listed to receive one after the trial finishes).
Group IV: -MCNS+WLPlacebo Group1 Intervention
This group receives the placebo nutrition supplement and the behavioral weight loss intervention.

Find a Location

Who is running the clinical trial?

Tufts UniversityLead Sponsor
270 Previous Clinical Trials
594,843 Total Patients Enrolled
20 Trials studying Obesity
106,151 Patients Enrolled for Obesity
Massachusetts General HospitalOTHER
3,026 Previous Clinical Trials
13,413,741 Total Patients Enrolled
74 Trials studying Obesity
292,486 Patients Enrolled for Obesity
University of FloridaOTHER
1,409 Previous Clinical Trials
767,175 Total Patients Enrolled
38 Trials studying Obesity
20,365 Patients Enrolled for Obesity
University of New HampshireOTHER
15 Previous Clinical Trials
105,445 Total Patients Enrolled
4 Trials studying Obesity
100,244 Patients Enrolled for Obesity
Susan B. Roberts, Ph.D.Principal InvestigatorJean Mayer USDA Human Nutrition Research Center on Aging

Media Library

MCNS (Multicomponent Nutrition Supplement) Clinical Trial Eligibility Overview. Trial Name: NCT05542199 — N/A
Obesity Research Study Groups: -MCNS-WL, +MCNS+WL, -MCNS+WL, +MCNS-WL
Obesity Clinical Trial 2023: MCNS Highlights & Side Effects. Trial Name: NCT05542199 — N/A
MCNS (Multicomponent Nutrition Supplement) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05542199 — N/A
~15 spots leftby Jan 2026